A unique systems pharmacology platform powered by AI to accelerate drug discovery. Uses disruptive AI technology to accelerate the entire drug discovery process by identifying promising candidates, de-risking the opportunities through preclinical validations, and progressing drug candidates to the clinic through industry and investor partnerships
Dexamethasone identified by AI VIVO as high potential for treatment of COVID-19 ten weeks ago
Investors 2
| Date | Name | Website |
| - | o2h ventur... | o2hventure... |
| - | Martlet | martletcap... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 22.09.2021 | Introducing: the 32 companies joining the Applied AI program... | We are excited to announce the 32 AI companies selected for the third iteration of Tech Nation’s App... | technation... |
| 07.05.2020 | AI VIVO seeks collaboration partners to progress top-ranked ... | AI VIVO seeks collaboration partners to progress top-ranked COVID-19 therapeutic candidates 07-05-2... | cambridgen... |
| 16.04.2020 | COVID-19 breakthrough as Cambridge company identifies top ra... | COVID-19 breakthrough as Cambridge company identifies top ranked drugs for treatment 16-04-2020 A ... | cambridgen... |